论文部分内容阅读
目的探讨输尿管镜钬激光碎石术联合通淋排石汤治疗输尿管中下段结石的临床疗效。方法选取重庆市江津区中医院2015年10月—2016年10月收治的输尿管中下段结石患者86例,根据随机抽签法将患者分为观察组与对照组,每组43例。观察组患者予以输尿管镜钬激光碎石术联合通淋排石汤治疗,对照组患者予以传统切开取石术联合通淋排石汤治疗。比较两组患者结石清除率、手术时间、术中出血量、住院时间、目测类比评分法(VAS)评分、术后并发症及复发情况。结果观察组患者结石清除率高于对照组,手术时间、住院时间短于对照组,术中出血量少于对照组,VAS评分、并发症发生率、复发率低于对照组(P<0.05)。结论输尿管镜钬激光碎石术联合通淋排石汤治疗输尿管中下段结石的临床疗效确切,可提高患者结石清除率,且安全性高。
Objective To investigate the clinical efficacy of ureteroscopic holmium laser lithotripsy combined with Tonglin Paishi Decoction for the treatment of middle and lower ureteral calculi. Methods 86 cases of ureteral calculi in the lower ureter from October 2015 to October 2016 in Jiangjin District Hospital of Chongqing were selected and divided into observation group and control group according to random sampling method, 43 cases in each group. Patients in the observation group were treated with ureteroscopic holmium laser lithotripsy combined with Tonglin Paishi Decoction, and patients in the control group were treated by traditional incision lithotomy combined with Tonglin Paishi Decoction. The stone clearance rate, operation time, intraoperative blood loss, hospital stay, visual analogue scale (VAS) score, postoperative complications and recurrence were compared between the two groups. Results The stone clearance rate in the observation group was higher than that in the control group. The operation time and hospital stay were shorter than those in the control group. The blood loss was less in the observation group than in the control group. The VAS score, complication rate and recurrence rate were lower than those in the control group (P <0.05) . Conclusions Ureteroscopic holmium laser lithotripsy combined with Tonglin Paishi Decoction for the treatment of middle and lower ureteral calculi has definite curative effect, which can improve the stone clearance rate and is safe.